[Dysimmune and inflammatory myopathies].

Abstract

Dysimmunes and inflammatory myopathies (DIM) are divided in four groups, on the grounds of clinical and histopathological criteria: dermatomyositis, polymyositis, inclusion body myositis and autoimmune necrotizing myopathy. They may present as unique condition (primary DIM), or in association with cancer (paraneoplastic DIM) or connective tissue disease (overlap syndrome). All of them but inclusion body myositis usually respond to immunomodulatory therapy, including steroids, immunosuppressive drugs, and intravenous immunglobulins. However, most often they are chronic diseases with relapses and therapeutic failure.

• Authors: François-Jérôme Authier
• Journal: La Revue du praticien (Rev Prat) Vol. 58 Issue 20 Pg. 2253-60 (Dec 31 2008) ISSN: 0035-2640 [Print] France
• Vernacular Title: Myopathies inflammatoires et dysimmunitaires.
• PMID: 19209656 (Publication Type: Comparative Study, English Abstract, Journal Article, Review)

Chemical References

• Adrenal Cortex Hormones
• Immunoglobulins, Intravenous
• Immunosuppressive Agents
• Creatine Kinase

Topics

• Adrenal Cortex Hormones (therapeutic use)
• Adult
• Autoimmune Diseases (diagnosis, therapy)
• Biopsy
• Clinical Enzyme Tests
• Creatine Kinase (blood)
• Dermatomyositis (diagnosis, pathology)
• Diagnosis, Differential
• Electromyography
• Family Practice
• Humans
• Immunoglobulins, Intravenous (therapeutic use)
• Immunosuppressive Agents (therapeutic use)
• Magnetic Resonance Imaging
• Muscle, Skeletal (pathology)
• Myositis (diagnosis, immunology, pathology, therapy)